IPM’s Damian Doherty and GEN’s Julianna LeMieux, PhD, spent three full days at the AACR meeting in Chicago. In this final video update, they share key takeaways from the event, including industry highlights and notable clinical trial results.

News & FeaturesArtificial intelligenceBiomedical researchCancersClinical trialGenomicsLiquid biopsySequencing
Also of Interest
New Methylation Profiling Assay for Liquid Biopsy
AMP President: AI, Regulation, and Labor Shortages Threaten Molecular Diagnostics
Emvena Therapeutics Emerges from Stealth to Target Preeclampsia
Common T-Cell Receptors Found in Multiple Cancers
AI Marginally Improves Mortality Prediction from Cardiac MRI
Surveillance Mammography Doesn't Improve Survival in Older Women with Breast Cancer History